Literature DB >> 18848819

Sepsis, apoptosis and complement.

P A Ward1.   

Abstract

Programmed cell death (apoptosis) is a prominent feature in human and experimental sepsis, especially as it involves the lymphoid system with resulting immunoparalysis. In addition, sepsis is associated with strong activation of the complement system, resulting in generation of the powerful anaphylatoxin, C5a, as well as the upregulation of the C5a receptor (C5aR) in a variety of different organs. The consequences of C5a interactions with C5aR can be directly linked to apoptosis of thymocytes and adrenal medullary cells after cecal ligation and puncture (CLP)-induced sepsis in rodents, as well as with other accompanying complications of CLP: cardiac dysfunction, consumptive coagulopathy, organ dysfunction, and lethality. This communication reviews the evidence for the adverse roles of C5a and C5aR in the setting of experimental sepsis and linkages to the various complications of sepsis, especially apoptosis as well as the roles of the two C5a receptors (C5aR and C5L2) in experimental sepsis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848819      PMCID: PMC2656915          DOI: 10.1016/j.bcp.2008.09.017

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

Authors:  R F Guo; M Huber-Lang; X Wang; V Sarma; V A Padgaonkar; R A Craig; N C Riedemann; S D McClintock; T Hlaing; M M Shi; P A Ward
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 3.  The role of complement in inflammation and adaptive immunity.

Authors:  R Barrington; M Zhang; M Fischer; M C Carroll
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

4.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

5.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

6.  Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.

Authors:  Ines J Laudes; Jeffrey C Chu; Sujata Sikranth; Markus Huber-Lang; Ren-Feng Guo; Niels Riedemann; J Vidya Sarma; Alvin H Schmaier; Peter A Ward
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

7.  Prevention of lymphocyte cell death in sepsis improves survival in mice.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; K C Chang; J P Cobb; T G Buchman; S J Korsmeyer; I E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

8.  Protective effects of anti-C5a peptide antibodies in experimental sepsis.

Authors:  M S Huber-Lang; J V Sarma; S R McGuire; K T Lu; R F Guo; V A Padgaonkar; E M Younkin; I J Laudes; N C Riedemann; J G Younger; P A Ward
Journal:  FASEB J       Date:  2001-01-19       Impact factor: 5.191

9.  Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality.

Authors:  S J Ebong; S M Goyert; J A Nemzek; J Kim; G L Bolgos; D G Remick
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

10.  The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Anthony J Chen; Brian A Nadeau; Danielle E Day; J Vidya Sarma; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  27 in total

Review 1.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

2.  G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Authors:  Hong-Mei Li; Ji Hye Jang; Jun-Sub Jung; Jiseon Shin; Chul O Park; Yeon-Ja Kim; Won-Gyun Ahn; Ju-Suk Nam; Chang-Won Hong; Jongho Lee; Yu-Jin Jung; Jiang-Fan Chen; Katya Ravid; H Thomas Lee; Won-Ki Huh; Janusz H Kabarowski; Dong-Keun Song
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

Review 3.  [Pathophysiological basis of surgery-linked sepsis].

Authors:  B Vollmar
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

4.  C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB.

Authors:  Alexander Jacob; Bradley Hack; Peili Chen; Richard J Quigg; Jessy J Alexander
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

5.  Chlorogenic acid attenuates high mobility group box 1 (HMGB1) and enhances host defense mechanisms in murine sepsis.

Authors:  Chan-Ho Lee; Seong-Jin Yoon; Sun-Mee Lee
Journal:  Mol Med       Date:  2013-01-22       Impact factor: 6.354

Review 6.  Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer.

Authors:  Jacob Gadwa; Sana D Karam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-07-03       Impact factor: 7.038

7.  Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction.

Authors:  David M Cauvi; Donghuan Song; Daniel E Vazquez; Dennis Hawisher; Jose A Bermudez; Michael R Williams; Stephen Bickler; Raul Coimbra; Antonio De Maio
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

8.  C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus.

Authors:  Supriya D Mahajan; Vincent M Tutino; Yonas Redae; Hui Meng; Adnan Siddiqui; Trent M Woodruff; James N Jarvis; Teresa Hennon; Stanley Schwartz; Richard J Quigg; Jessy J Alexander
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

Review 9.  Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective.

Authors:  Manu Shankar-Hari; Jo Spencer; William A Sewell; Kathryn M Rowan; Mervyn Singer
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

10.  New insights for C5a and C5a receptors in sepsis.

Authors:  Chunguang Yan; Hongwei Gao
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.